Heart Test Laboratories Stock Performance

HSCSW Stock  USD 0.11  0.00  0.00%   
Heart Test holds a performance score of 15 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 2.6, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Heart Test will likely underperform. Use Heart Test Laboratories information ratio, as well as the relationship between the value at risk and kurtosis , to analyze future returns on Heart Test Laboratories.

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Heart Test Laboratories are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Heart Test showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor
1:100
Last Split Date
2024-05-17
1
Acquisition by Andrew Simpson of 70000 shares of Heart Test at 0.001 subject to Rule 16b-3
11/25/2025
2
Heart Test Laboratories Approves Indemnification Agreement - TipRanks
12/16/2025
3
Acquisition by Danielle Watson of 15000 shares of Heart Test subject to Rule 16b-3
12/22/2025
4
Cardio Diagnostics stock rises on strategic expansion into India - Investing.com
12/31/2025
5
Acquisition by Bent Bruce of 15000 shares of Heart Test subject to Rule 16b-3
01/12/2026
6
Heart biopsy alternative 300-patient trial of Natera blood test fully enrolled - Stock Titan
01/28/2026
Begin Period Cash Flow5.8 M
Total Cashflows From Investing Activities-30.2 K

Heart Test Relative Risk vs. Return Landscape

If you would invest  6.50  in Heart Test Laboratories on November 4, 2025 and sell it today you would earn a total of  4.50  from holding Heart Test Laboratories or generate 69.23% return on investment over 90 days. Heart Test Laboratories is currently producing 9.9505% returns and takes up 51.7045% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Heart, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Heart Test is expected to generate 69.54 times more return on investment than the market. However, the company is 69.54 times more volatile than its market benchmark. It trades about 0.19 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.09 per unit of risk.

Heart Test Target Price Odds to finish over Current Price

The tendency of Heart Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.11 90 days 0.11 
about 15.5
Based on a normal probability distribution, the odds of Heart Test to move above the current price in 90 days from now is about 15.5 (This Heart Test Laboratories probability density function shows the probability of Heart Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon the stock has the beta coefficient of 2.6 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Heart Test will likely underperform. In addition to that Heart Test Laboratories has an alpha of 5.0134, implying that it can generate a 5.01 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Heart Test Price Density   
       Price  

Predictive Modules for Heart Test

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Heart Test Laboratories. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Heart Test's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.010.1255.62
Details
Intrinsic
Valuation
LowRealHigh
0.010.1055.60
Details
Naive
Forecast
LowNextHigh
00.1251.83
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.040.10.15
Details

Heart Test Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Heart Test is not an exception. The market had few large corrections towards the Heart Test's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Heart Test Laboratories, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Heart Test within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
5.01
β
Beta against Dow Jones2.60
σ
Overall volatility
0.03
Ir
Information ratio 0.14

Heart Test Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Heart Test for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Heart Test Laboratories can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Heart Test is way too risky over 90 days horizon
Heart Test has some characteristics of a very speculative penny stock
Heart Test appears to be risky and price may revert if volatility continues
Heart Test has high likelihood to experience some financial distress in the next 2 years
Heart Test Laboratories has accumulated 2.99 M in total debt. Heart Test Laboratories has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about Heart Test's use of debt, we should always consider it together with its cash and equity.
The entity reported the revenue of 4.35 K. Net Loss for the year was (8.77 M) with profit before overhead, payroll, taxes, and interest of 5.02 K.
Heart Test Laboratories has accumulated about 723.48 K in cash with (7.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.22, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Heart Test has a frail financial position based on the latest SEC disclosures
Latest headline from prnewswire.com: REDKEN NAMED OFFICIAL HAIR CARE PARTNER OF THE 2026 GRAMMY AWARDS

Heart Test Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Heart Stock often depends not only on the future outlook of the current and potential Heart Test's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Heart Test's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding938.3 K
Cash And Short Term Investments1.1 M

Heart Test Fundamentals Growth

Heart Stock prices reflect investors' perceptions of the future prospects and financial health of Heart Test, and Heart Test fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Heart Stock performance.

About Heart Test Performance

Evaluating Heart Test's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Heart Test has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Heart Test has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand2.1 KK
Return On Tangible Assets(3.87)(4.06)
Return On Capital Employed(18.48)(17.56)
Return On Assets(1.87)(1.96)
Return On Equity(49.13)(46.67)

Things to note about Heart Test Laboratories performance evaluation

Checking the ongoing alerts about Heart Test for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Heart Test Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Heart Test is way too risky over 90 days horizon
Heart Test has some characteristics of a very speculative penny stock
Heart Test appears to be risky and price may revert if volatility continues
Heart Test has high likelihood to experience some financial distress in the next 2 years
Heart Test Laboratories has accumulated 2.99 M in total debt. Heart Test Laboratories has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about Heart Test's use of debt, we should always consider it together with its cash and equity.
The entity reported the revenue of 4.35 K. Net Loss for the year was (8.77 M) with profit before overhead, payroll, taxes, and interest of 5.02 K.
Heart Test Laboratories has accumulated about 723.48 K in cash with (7.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.22, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Heart Test has a frail financial position based on the latest SEC disclosures
Latest headline from prnewswire.com: REDKEN NAMED OFFICIAL HAIR CARE PARTNER OF THE 2026 GRAMMY AWARDS
Evaluating Heart Test's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Heart Test's stock performance include:
  • Analyzing Heart Test's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Heart Test's stock is overvalued or undervalued compared to its peers.
  • Examining Heart Test's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Heart Test's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Heart Test's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Heart Test's stock. These opinions can provide insight into Heart Test's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Heart Test's stock performance is not an exact science, and many factors can impact Heart Test's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Heart Stock Analysis

When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.